Lung neuroendocrine neoplasms: a single centre surgical series and analysis of staging

Abstract

AbstractBackgroundTo review the outcomes of surgically resected lung neuroendocrine neoplasms (LNEN) at a tertiary referral centre and to validate a previously published LNEN‐specific staging system (NETL).MethodsAll patients who were identified on histopathology to have LNEN were included. Pre‐, intra‐ and post‐operative outcomes were collected, including long‐term survival. Patients were staged by both the TNM (seventh and eighth edition) and NETL staging (seventh and eighth edition definitions). Kaplan–Meier (KM) survival analysis was performed according to histopathology and stage, along with uni‐ and multivariate analyses.ResultA total of 132 patients were included in the study, with a median age of 65 years; 55% were female. Typical carcinoid (TC) was the most common pathology (53.4%) followed by large cell neuroendocrine carcinoma (LCNEC – 23.5%), atypical carcinoid (AC – 20.5%) and small cell carcinoma (3.0%). The most common operation performed was a lobectomy (55.3%). Overall survival at 5 years was 80% (100% TC, 78.2% AC, LCNEC 40.9%) and 5‐year disease free survival was 76.8% (TC 94.3%, AC 56.8%, LCNEC 56.4%). KM curves showed a trend towards NETL performing better than TNM, however, in multivariate analysis only the histological subtype was found to be significant in our study.ConclusionThis is the largest known Australian series of LNEN to date, showing survival comparable to international outcomes. We have demonstrated large variations in outcome, driven by histological grade. The TNM system does not correlate with survival and we have not been able to show that currently proposed NETL staging is superior.